Issued Patents All Time
Showing 1–23 of 23 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11648260 | Vesicles comprising a PTEN inhibitor and uses of same | Shulamit Levenberg, Shaowei Guo, Nisim PERETS | 2023-05-16 |
| 11185572 | Mesenchymal stem cells for the treatment of CNS diseases | Avinoam Kadouri, Avihay Bar-Ilan, Eldad Melamed, Ofer Sadan, Merav Bahat-Stromza | 2021-11-30 |
| 11129852 | Mesenchymal cell-derived exosomes to treat neurological disorders | Nisim PERETS | 2021-09-28 |
| 11104651 | PERK inhibitors and uses thereof in treating diseases associated with aggregation-prone proteins | Gerardo Zelmar LEDERKREMER, Julia Leitman, Hagit Eiger, Javier Ganz, Moshe Portnoy | 2021-08-31 |
| 10869899 | Isolated cells and populations comprising same for the treatment of CNS diseases | Merav Bahat-Stromza, Eldad Melamed | 2020-12-22 |
| 10744162 | Genetically modified muscle cells which express neurotrophic factors | Michal Dadon-Nachum, Tali Ben-Zur, Eldad Melamed, David Yaffe | 2020-08-18 |
| 10723706 | Perk inhibitors and uses thereof in treating diseases associated with aggregation-prone proteins | Gerardo Zelmar LEDERKREMER, Julia Leitman, Hagit Eiger, Javier Ganz, Moshe Portnoy | 2020-07-28 |
| 10220077 | Combination treatment for amyotrophic lateral sclerosis (ALS) | Chen Benkler | 2019-03-05 |
| 10052363 | Mesenchymal stem cells for the treatment of CNS diseases | Avinoam Kadouri, Avihay Bar-Ilan, Eldad Melamed, Ofer Sadan, Merav Bahat-Stromza | 2018-08-21 |
| 10040836 | Peptides for the treatment of neurodegenerative diseases | Israel Aharony | 2018-08-07 |
| 9879225 | Isolated cells and populations comprising same for the treatment of CNS diseases | Merav Bahat-Stromza, Eldad Melamed | 2018-01-30 |
| 9717761 | Stem cell-derived neural cells for cell therapy in neurological disorders | Sandu Pitaru, Javier Ganz, Eldad Melamed | 2017-08-01 |
| 9598478 | Peptides for the treatment of neurodegenerative diseases | Israel Aharony | 2017-03-21 |
| 9474787 | Mesenchymal stem cells for the treatment of CNS diseases | Avinoam Kadouri, Avihay Bar-Ilan, Eldad Melamed, Ofer Sadan, Merav Bahat-Stromza | 2016-10-25 |
| 9365828 | Genetically modified muscle cells which express neurotrophic factors | Michal Dadon-Nachum, Tali Ben-Zur, Eldad Melamed, David Yaffe | 2016-06-14 |
| 9023800 | Peptides for the treatment of oxidative stress related disorders | Nirit Lev, Eldad Melamed | 2015-05-05 |
| 8900574 | Mesenchymal stem cells for the treatment of CNS diseases | Avinoam Kadouri, Avihay Bar-Ilan, Eldad Melamed, Ofer Sadan, Merav Bahat-Stromza | 2014-12-02 |
| 8663987 | Mesenchymal stem cells for the treatment of CNS diseases | Avinoam Kadouri, Avihay Bar-Ilan, Eldad Melamed, Ofer Sadan, Merav Bahat-Stromza | 2014-03-04 |
| 8647874 | Isolated cells and populations comprising same for the treatment of CNS diseases | Merav Bahat-Stromza, Eldad Melamed | 2014-02-11 |
| 8378070 | Peptides for the regulation of neurotransmitter sequestration and release | Nirit Lev, Eldad Melamed | 2013-02-19 |
| 8212001 | Peptides for the treatment of oxidative stress related disorders | Nirit Lev, Eldad Melamed | 2012-07-03 |
| 6420429 | Brain targeted low molecular weight hydrophobic antioxidant compounds | Daphne Atlas, Eldad Melamed | 2002-07-16 |
| 6369106 | Treatment of ischemic brain injuries with brain targeted anti oxidant compounds | Daphne Atlas, Eldad Melamed | 2002-04-09 |